A Study of KC1036 in Patients With Advanced Thymic Tumors
Status:
Not yet recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This is a single arm，open-label, multicentric, phase II study to evaluate the efficacy and
safety of KC1036 in patients with advanced recurrent or metastatic thymoma or thymic
carcinoma.